Adhering to these criteria, we carried out a study to evaluate two different methods of assessing Ki67, MCM2 and Geminin IHC in tissue microarrays (TMAs) of a series of consecutive invasive breast cancer cases. Here, GMNN is linked to invasive breast carcinoma.